SCHEMBL394058

SCHEMBL394058

C[S+](C)CC(=O)c1ccccc1.F[B-](F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
KMT2A Q03164 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 3/20 0.48
MAPK1 P28482 2/20 0.48
MEN1 O00255 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
KDM4E B2RXH2 2/20 0.48
CYP3A4 P08684 2/20 0.48
ALOX15 P16050 1/20 0.48
CES1 P23141 1/20 0.48
ALDH1A1 P00352 5/20 0.45
GSK3B P49841 3/20 0.45
PTPN1 P18031 3/20 0.45
HIF1A Q16665 2/20 0.45
TRPA1 O75762 1/20 0.45
L3MBTL1 Q9Y468 5/20 0.44
NPC1 O15118 2/20 0.44
RAB9A P51151 1/20 0.44
LMNA P02545 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL686321 0.92 KMT2A (0.56) MAPTKMT2ASMN1; SMN2HPGDMAPK1
Hydrochloric Acid SCHEMBL60929 0.90 KMT2A (0.54) MAPTKMT2ASMN1; SMN2HPGDMAPK1
Bromide SCHEMBL394250 0.90 KMT2A (0.54) MAPTKMT2ASMN1; SMN2HPGDMAPK1
SCHEMBL30112595 0.89 KMT2A (0.48) MAPTKMT2ASMN1; SMN2HPGDMAPK1
SCHEMBL8150640 0.85 MAPT (0.45) MAPTKMT2ASMN1; SMN2HPGDMAPK1
SCHEMBL10405142 0.85 LMNA (0.46) MAPTKMT2ASMN1; SMN2HPGDMAPK1
Dimethylamine SCHEMBL6289518 0.85 KMT2A (0.54) MAPTKMT2ASMN1; SMN2HPGDMAPK1
SCHEMBL5666293 0.84 L3MBTL1 (0.44) MAPTKMT2ASMN1; SMN2HPGDMAPK1
SCHEMBL8756107 0.81 KMT2A (0.42) MAPTKMT2ASMN1; SMN2HPGDMAPK1
SCHEMBL8757397 0.81 MAPT (0.42) MAPTKMT2ASMN1; SMN2HPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173584-B2 Composition and method for treating semiconductor substrate surface LASERWORT LTD (HK) 2012-05-08 US claimed
US-20120083436-A1 COMPOSITION AND METHOD FOR TREATING SEMICONDUCTOR SUBSTRATE SURFACE LASERWORT LTD (HK) 2012-04-05 US claimed
US-8101561-B2 Composition and method for treating semiconductor substrate surface LASERWORT LTD (HK) 2012-01-24 US claimed
US-20110118165-A1 COMPOSITION AND METHOD FOR TREATING SEMICONDUCTOR SUBSTRATE SURFACE Lee, Wai Mun (US) 2011-05-19 US claimed
US-20260117026-A1 DIELECTRIC MATERIALS BASED ON HETEROAROMATIC-EXTENDED BISMALEIMIDES MERCK PATENT GMBH (DE) 2026-04-30 US disclosed
US-20260098128-A1 CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF DOW TORAY CO LTD (JP) 2026-04-09 US disclosed
US-12583975-B2 UV-curable organopolysiloxane composition and use thereof DOW TORAY CO., LTD. (JP) 2026-03-24 US disclosed
US-20260050218-A1 PHENOLIC HYDROXYL GROUP-CONTAINING BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF DOW TORAY CO LTD (JP) 2026-02-19 US disclosed
US-20260049187-A1 CO-MODIFIED BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME DOW TORAY CO LTD (JP) 2026-02-19 US disclosed
US-20260022202-A1 UV-CURABLE COMPOSITION AND USE THEREOF DOW TORAY CO LTD (JP) 2026-01-22 US disclosed
US-20260022270-A1 CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME DOW TORAY CO LTD (JP) 2026-01-22 US disclosed
US-12503555-B2 Solventless photocurable liquid composition, cured product thereof, optical filler containing same, and display device including layer comprising said cured product DOW TORAY CO., LTD. (JP) 2025-12-23 US disclosed
US-5830949-A Adhesive resin composition and adhesive sheet NITTO DENKO CORPORATION (JP) 1998-11-03 US disclosed
US-5663256-A Thermosetting aqueous-type emulsion of nadimides MARUZEN PETROCHEMICAL CO., LTD. (JP) 1997-09-02 US disclosed
US-5663257-A LAMINATING AND MOLDING MATERIAL, MATRIX FOR COMPOSITES; HEAT RESISTANCE AND BOILING WATER RESISTANCE MARUZEN PETROCHEMICAL CO., LTD. (JP) 1997-09-02 US disclosed
EP-0555058-B1 (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition TOYO INK MFG CO (JP) 1997-05-07 EP disclosed
US-5521260-A ALKENYLNADIMIDE, VINYL COMPOUND, PHENOLIC RESIN MARUZEN PETROCHEMICAL CO., LTD. (JP) 1996-05-28 US disclosed
US-5502207-A ALKENYL-SUBSTITUTED BISNADIMIDE MARUZEN PETROCHEMICAL CO., LTD. (JP) 1996-03-26 US disclosed
US-5500453-A INITIATOR FOR PHOTOSENSITIVE FREE RADICAL CURING/ POLYMERIZATION OF UNSATURATED COMPOUNDS TOYO INK MANUFACTURING CO., LTD. (JP) 1996-03-19 US disclosed
EP-0555058-A1 (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition TOYO INK MANUFACTURING CO., LTD. (JP) 1993-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022270-A1 CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME PLOD3, PLOD2, PLOD1 MAPT 3901/4885KMT2A 2189/4885SMN1; SMN2 299/4885
US-20260050218-A1 PHENOLIC HYDROXYL GROUP-CONTAINING BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF MSR1, HAO2, HAO1 MAPT 3880/4885KMT2A 1660/4885SMN1; SMN2 158/4885
US-20260049187-A1 CO-MODIFIED BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE OF SAME MSR1, HAO2, COL2A1 MAPT 3578/4885KMT2A 1184/4885SMN1; SMN2 16/4885
US-20260098128-A1 CURABLE BRANCHED ORGANOPOLYSILOXANE, HIGH ENERGY RAY-CURABLE COMPOSITION CONTAINING SAME, AND USE THEREOF COL2A1, COL1A1, SEM1 MAPT 3200/4885KMT2A 1699/4885SMN1; SMN2 99/4885
US-20260117026-A1 DIELECTRIC MATERIALS BASED ON HETEROAROMATIC-EXTENDED BISMALEIMIDES KCNE1, GLRB, PBRM1 MAPT 2622/4885KMT2A 1059/4885SMN1; SMN2 2207/4885
US-20260022202-A1 UV-CURABLE COMPOSITION AND USE THEREOF IDUA, SEM1, ARSA MAPT 1608/4885KMT2A 2479/4885SMN1; SMN2 361/4885
US-12583975-B2 UV-curable organopolysiloxane composition and use thereof F12, FUCA1, XPA MAPT 4363/4885KMT2A 2958/4885SMN1; SMN2 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.